| MeSH term | MeSH ID | Detail |
|---|---|---|
| Starvation | D013217 | 47 associated lipids |
| Tuberculosis, Multidrug-Resistant | D018088 | 6 associated lipids |
Total
2
D-cycloserine
D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.
Cross Reference
Introduction
To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with D-cycloserine?
D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with D-cycloserine
PubChem Associated disorders and diseases
What pathways are associated with D-cycloserine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with D-cycloserine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with D-cycloserine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with D-cycloserine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with D-cycloserine?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with D-cycloserine?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with D-cycloserine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Park SI et al. | Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers. | 2015 | Antimicrob. Agents Chemother. | pmid:25987620 |
| Urbano M et al. | A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder. | 2014 May-Jun | Clin Neuropharmacol | pmid:24824660 |
| Gazarini L et al. | PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation. | 2014 | Int. J. Neuropsychopharmacol. | pmid:25539509 |
| Warmus BA et al. | Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia. | 2014 | J. Neurosci. | pmid:25471585 |
| Rathnaiah G et al. | Generation and screening of a comprehensive Mycobacterium avium subsp. paratuberculosis transposon mutant bank. | 2014 | Front Cell Infect Microbiol | pmid:25360421 |
| Chow SE et al. | Resveratrol induced ER expansion and ER caspase-mediated apoptosis in human nasopharyngeal carcinoma cells. | 2014 | Apoptosis | pmid:24264887 |
| Venir E et al. | Involvement of alanine racemase in germination of Bacillus cereus spores lacking an intact exosporium. | 2014 | Arch. Microbiol. | pmid:24346000 |
| Huang TN et al. | Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality. | 2014 | Nat. Neurosci. | pmid:24441682 |
| Muscia GC et al. | Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents. | 2014 | Eur J Med Chem | pmid:24412719 |
| Mpagama SG et al. | Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. | 2014 | Antimicrob. Agents Chemother. | pmid:24247125 |
| Ribbens JJ et al. | Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease. | 2014 | Mol. Genet. Metab. | pmid:24094551 |
| Rothbaum BO et al. | A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. | 2014 | Am J Psychiatry | pmid:24743802 |
| Linares IM et al. | Neuroimaging correlates of pharmacological and psychological treatments for specific phobia. | 2014 | CNS Neurol Disord Drug Targets | pmid:24923351 |
| Hung WY et al. | Serum concentrations of cycloserine and outcome of multidrug-resistant tuberculosis in Northern Taiwan. | 2014 | Int. J. Tuberc. Lung Dis. | pmid:24903799 |
| Donzis EJ and Thompson LT | D-cycloserine enhances both intrinsic excitability of CA1 hippocampal neurons and expression of activity-regulated cytoskeletal (Arc) protein. | 2014 | Neurosci. Lett. | pmid:24793770 |
| Hong W et al. | Molecular basis underlying Mycobacterium tuberculosis D-cycloserine resistance. Is there a role for ubiquinone and menaquinone metabolic pathways? | 2014 | Expert Opin. Ther. Targets | pmid:24773568 |
| Handford CE et al. | The effect of the mGlu5 negative allosteric modulator MTEP and NMDA receptor partial agonist D-cycloserine on Pavlovian conditioned fear. | 2014 | Int. J. Neuropsychopharmacol. | pmid:24674862 |
| Kugathasan R et al. | Cycloserine as an alternative urinary tract infection therapy: susceptibilities of 500 urinary pathogens to standard and alternative therapy antimicrobials. | 2014 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:24474246 |
| Baran H and Kepplinger B | D-Cycloserine lowers kynurenic acid formation--new mechanism of action. | 2014 | Eur Neuropsychopharmacol | pmid:24189377 |
| Shohami E and Biegon A | Novel approach to the role of NMDA receptors in traumatic brain injury. | 2014 | CNS Neurol Disord Drug Targets | pmid:24168367 |